Economic value of atopic dermatitis prevention via infant formula use in high-risk Malaysian infants.

Bhanegaonkar, Abhijeet J; Horodniceanu, Erica G; Abdul Latiff, Amir Hamzah; Woodhull, Sanjay; Khoo, Phaik Choo; Detzel, Patrick; Ji, Xiang; Botteman, Marc F

Bhanegaonkar, Abhijeet J; Horodniceanu, Erica G; Abdul Latiff, Amir Hamzah; Woodhull, Sanjay; Khoo, Phaik Choo; Detzel, Patrick; Ji, Xiang; Botteman, Marc F.

Afiliação

Bhanegaonkar AJ; Pharmerit International, Bethesda, MD 20814, USA.
Horodniceanu EG; Pharmerit International, Bethesda, MD 20814, USA.
Abdul Latiff AH; Department of Pediatrics, Pantai Hospital Kuala Lumpur, 59100 Kuala Lumpur, Malaysia.
Woodhull S; Department of Pediatrics, Ramsay Sime Darby, Subang Jaya Medical Centre, 47500 Subang Jaya, Malaysia.
Khoo PC; Department of Pediatrics, Ramsay Sime Darby, Subang Jaya Medical Centre, 47500 Subang Jaya, Malaysia.
Detzel P; Nestlé Research Center, 1000 Lausanne 26, Switzerland.
Ji X; Pharmerit International, Bethesda, MD 20814, USA.
Botteman MF; Pharmerit International, Bethesda, MD 20814, USA.

Asia Pac Allergy ; 5(2): 84-97, 2015 Apr.

Article em En | MEDLINE | ID: mdl-25938073

Palavras-chave

Cost-benefit analysis; Dermatitis atopic; Infant formula

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Etiology_studies / Health_economic_evaluation / Risk_factors_studies Idioma: En Revista: Asia Pac Allergy Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google